Antidepressant treatments regulate matrix metalloproteinases‐2 and ‐9 (MMP‐2/MMP‐9) and tissue inhibitors of the metalloproteinases (TIMPS 1–4) in the adult rat hippocampus
- 29 May 2008
- Vol. 62 (8), 590-600
- https://doi.org/10.1002/syn.20529
Abstract
Antidepressants induce structural remodeling in the adult hippocampus, including changes in dendritic arbors, axonal sprouting, neurogenesis, and endothelial cell proliferation. Such forms of structural plasticity take place in the context of the extracellular matrix environment and are known to be regulated by matrix metalloproteinases (MMPs), in particular MMP-2/9, and their endogenous regulators, the tissue inhibitors of the metalloproteinases (TIMPs 1–4). Given the hippocampal structural remodeling associated with antidepressant treatments, we hypothesized that antidepressants may regulate the expression and activity of MMP-2/9 and TIMPs 1–4. The influence of distinct classes of antidepressants, namely, electroconvulsive seizure, fluoxetine, tranylcypromine, and desipramine, on the gene expression of MMP-2, MMP-9, and TIMPs 1–4 in the hippocampus was determined using radioactive in situ hybridization. In addition, zymography studies addressed the regulation of the gelatinase activity of MMP-2/9 following acute and chronic antidepressant administration. We observed that acute and chronic ECS differentially regulate the transcript levels of MMP-2/9 and TIMPs 1–4 and also increase gelatinase activity in the hippocampus. Acute and chronic pharmacological antidepressants on the other hand differentially alter the expression of the TIMPs without any observed effect on hippocampal MMP-2/9 expression or activity. These findings raise the possibility that extracellular matrix modifying enzymes and their endogenous regulators may serve as targets for antidepressant treatments and suggests the possibility that they may contribute to antidepressant-mediated structural plasticity in the hippocampus. Synapse 62:590–600, 2008.Keywords
This publication has 53 references indexed in Scilit:
- High-Speed Imaging Reveals Neurophysiological Links to Behavior in an Animal Model of DepressionScience, 2007
- In Vivo Roles for Matrix Metalloproteinase-9 in Mature Hippocampal Synaptic Physiology and PlasticityJournal of Neurophysiology, 2007
- Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteasesChinese Medical Journal, 2006
- Matrix metalloproteinase‐7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activationJournal of Neurochemistry, 2006
- Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brainFEBS Letters, 2004
- Electroconvulsive Seizures Regulate Gene Expression of Distinct Neurotrophic Signaling PathwaysJournal of Neuroscience, 2004
- Differential regulation of Brain Derived Neurotrophic Factor transcripts by antidepressant treatments in the adult rat brainNeuropharmacology, 2003
- Neural plasticity to stress and antidepressant treatmentBiological Psychiatry, 1999
- The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical developmentJCI Insight, 1999
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997